BackQuantum BioPharma Overview

Quantum BioPharma EBIT

EBIT (Earnings Before Interest and Taxes) analysis for QNTM.

Quarterly EBIT

-$2.87M
65.7% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$19.44M
8.11% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)